Taiwan FDA registration f8db63680d3c4c62598304a4913782b3

Nofasiderence amoeba immunoglobulin G enzyme immunoassay kit (unsterilized)

TW: 諾法鐵痢疾阿米巴免疫球蛋白G酵素免疫分析試劑套組(未滅菌)
Taiwan flagTaiwan·Risk Class 1·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Mar 10, 2022 – Mar 10, 2027Active
Registration details
Analysis ID
f8db63680d3c4c62598304a4913782b3
Customs Code
DHA09402275509
Company information
Manufacturer Country
Germany
Authorized Representative
EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
Intended Use
Classification and Grading Management Measures for Medical Devices Limited to the Identification Range of the First Grade of Dysentery Amoeba Serological Reagent (C.3220).
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3220 痢疾阿米巴血清試劑
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Mar 10, 2022
Expiry Date
Mar 10, 2027
About this record

Access comprehensive regulatory information for Nofasiderence amoeba immunoglobulin G enzyme immunoassay kit (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f8db63680d3c4c62598304a4913782b3 and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices